June Raine,
MD

Dr. June Raine trained in general medicine in Oxford after completing a Master degree by research in Pharmacology.  Her interest in drug safety led to a career in medicines regulation which has spanned a number of roles in assessment, management and strategic development within the UK national authority.

Appointed in 1999 to head Pharmacovigilance in the Medicines Control Agency (now Medicines and Healthcare Products Regulatory Agency), she was elected in 2005 to chair the CHMP’s Pharmacovigilance Working Party and in 2012 as the first chair of the Pharmacovigilance Risk Assessment Committee.  She is also a member of the WHO Advisory Committee on Safety of Medicinal Products. Her special interests are in monitoring the outcomes of regulatory action, risk communication and patient involvement in the regulatory process.

She has made outstanding contributions towards delivering a world-class European Union pharmacovigilance system. She has served as DIA EuroMeeting Programme co-Chair and has been a welcomed Speaker at DIA.